7月7日,湖北省知识产权局公布了第二届湖北专利奖授奖决定。东阳光药发明专利“作为丙型肝炎抑制剂的桥环化合物及其制备方法”(专利号ZL201510939448.4)荣获第二届湖北专利金奖,充分肯定了磷酸依米他韦在丙肝治疗领域的创新突破及其为临床带来的重要价值。值得注意的是,此前在6月,东阳光药发明专利“磷酸奥司他韦颗粒剂及其制备方法”(专利号ZL200610066995.7)刚斩获第二十五届中国专利...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.